Navigating Insurance Coverage Expansion (NICE)
Public ClinicalTrials.gov record NCT04263441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Navigating Insurance Coverage Expansion (NICE): A Collaboration to Increase Access to Care for Black and Hispanic Men Who Have Sex With Men and Transgender Persons
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this research is to measure the effectiveness of an in-person assistance intervention on successful insurance enrollment, types of insurance coverage, rates of linkage to and retention in HIV-related health care, referrals to other HIV-associated health services, and health outcomes. The study population is Black and Hispanic men who have sex with men (MSM) and transgender persons who are at higher risk for HIV. The study team will be testing the hypotheses that in-person health insurance enrollment assistance results in positive outcomes with regard to linkage to and retention in HIV-related health care. Analyses will be used to assess the efficacy of the intervention as an emerging practice.
Study identification
- NCT ID
- NCT04263441
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 630 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 17, 2018
- Primary completion
- Mar 15, 2020
- Completion
- May 13, 2021
- Last update posted
- Nov 15, 2022
2018 – 2021
United States locations
- U.S. sites
- 3
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Howard Brown Health | Chicago | Illinois | 60613 | — |
| Chicago House and Social Service Agency, Inc. | Chicago | Illinois | 60614 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated HIV/AIDS trials
Other public records listing HIV/AIDS. Sorted by last update posted; newest first. Not a recommendation.
- NCT03729778: Impact of HIV-1 and Aging on Mucosal Vaccine Responses Active, not recruiting
- NCT06462807: Enhancing the Organizational Social Context to Improve Viral Suppression and Retention in HIV Care Recruiting
- NCT05877729: Intervention for Virologic Suppression in Youth Active, not recruiting
- NCT06741618: MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM Recruiting
- NCT04019197: Effects of Semaglutide in HIV-Associated Lipohypertrophy Active, not recruiting
- NCT04378439: Appalachian Partnership to Reduce Disparities (Aim 2) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04263441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 15, 2022 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04263441 live on ClinicalTrials.gov.